NO871111L - Tertiaere hydroksyalkylxantiner, fremgangsmaate til deres fremstilling, legemidler som inneholder dem og deres anvendelse. - Google Patents
Tertiaere hydroksyalkylxantiner, fremgangsmaate til deres fremstilling, legemidler som inneholder dem og deres anvendelse.Info
- Publication number
- NO871111L NO871111L NO871111A NO871111A NO871111L NO 871111 L NO871111 L NO 871111L NO 871111 A NO871111 A NO 871111A NO 871111 A NO871111 A NO 871111A NO 871111 L NO871111 L NO 871111L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxylylxantines
- tertiary
- procedures
- preparation
- pharmaceuticals containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853525801 DE3525801A1 (de) | 1985-07-19 | 1985-07-19 | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
PCT/EP1986/000401 WO1987000523A2 (en) | 1985-07-19 | 1986-07-08 | Tertiary hydroxyalkylxanthines, their manufacturing process, medicines containing them and use thereof |
Publications (4)
Publication Number | Publication Date |
---|---|
NO871111L true NO871111L (no) | 1987-03-18 |
NO871111D0 NO871111D0 (no) | 1987-03-18 |
NO165803B NO165803B (no) | 1991-01-02 |
NO165803C NO165803C (no) | 1991-04-10 |
Family
ID=6276182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO871111A NO165803C (no) | 1985-07-19 | 1987-03-18 | Analogifremgangsmaate for fremstilling av terapeutisk aktive tertiaere hydroksyalkylxantiner. |
Country Status (33)
Country | Link |
---|---|
US (1) | US4833146A (no) |
EP (1) | EP0268585B1 (no) |
JP (1) | JPH0788382B2 (no) |
KR (1) | KR950001019B1 (no) |
CN (1) | CN1026112C (no) |
AR (1) | AR244689A1 (no) |
AT (1) | ATE53211T1 (no) |
AU (1) | AU588350B2 (no) |
BG (1) | BG60767B2 (no) |
CA (1) | CA1262248A (no) |
CS (1) | CS272766B2 (no) |
DD (1) | DD261156A5 (no) |
DE (2) | DE3525801A1 (no) |
DK (1) | DK157867C (no) |
ES (1) | ES2001019A6 (no) |
FI (1) | FI89921C (no) |
GR (1) | GR861866B (no) |
HU (1) | HU198486B (no) |
IE (1) | IE59025B1 (no) |
IL (1) | IL79457A0 (no) |
LT (1) | LT3869B (no) |
LV (1) | LV5703A3 (no) |
MA (1) | MA20739A1 (no) |
MX (1) | MX9254A (no) |
NO (1) | NO165803C (no) |
NZ (1) | NZ216888A (no) |
OA (1) | OA08707A (no) |
PH (1) | PH26262A (no) |
PT (1) | PT83013B (no) |
RU (1) | RU2051918C1 (no) |
TN (1) | TNSN86111A1 (no) |
WO (1) | WO1987000523A2 (no) |
ZA (1) | ZA865374B (no) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8621870D0 (en) * | 1986-09-11 | 1986-10-15 | Beecham Group Plc | Active compounds |
US5338741A (en) * | 1986-10-27 | 1994-08-16 | Nestec S.A. | 1-hydroxyalkylxanthines and medicaments containing them |
JP2661666B2 (ja) * | 1988-02-19 | 1997-10-08 | ヘキスト薬品工業株式会社 | 抗消化性潰瘍剤 |
GB8826595D0 (en) * | 1988-11-14 | 1988-12-21 | Beecham Wuelfing Gmbh & Co Kg | Active compounds |
DD298051A5 (de) * | 1989-08-16 | 1992-02-06 | ��@���������@�������k�� | Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten |
GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
EP0430300A3 (en) * | 1989-12-01 | 1992-03-25 | Takeda Chemical Industries, Ltd. | Xanthine derivatives, their production and use |
DE3942872A1 (de) * | 1989-12-23 | 1991-06-27 | Hoechst Ag | Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen |
IT1240843B (it) * | 1990-05-24 | 1993-12-17 | Malesci Istituto Farmacobiologico | Derivati xantinici 1-7 sostituiti ad attivita' antiasmatica, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche e procedimento per la loro preparazione. |
DE4019892A1 (de) * | 1990-06-22 | 1992-01-02 | Boehringer Ingelheim Kg | Neue xanthinderivate |
US5039666A (en) * | 1990-10-30 | 1991-08-13 | Hoechst-Roussel Pharmaceuticals Inc. | Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside |
DK0484785T3 (da) * | 1990-11-07 | 1996-09-23 | Hoechst Marion Roussel Inc | Anvendelse af xanthiner til fremstilling af et lægemiddel, der er virksomt til inhibering af formeringen af humane retrovira |
US6420374B1 (en) | 1990-11-30 | 2002-07-16 | Fred Hutchinson Cancer Research Center | Use of xanthines as immunosuppressants and to inhibit allograft reactions |
MX9203323A (es) * | 1991-07-11 | 1994-07-29 | Hoechst Ag | El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales. |
TW209834B (no) * | 1991-12-11 | 1993-07-21 | Hoechst Ag | |
DE59304710D1 (de) * | 1992-02-22 | 1997-01-23 | Hoechst Ag | Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation |
DK0584347T3 (da) * | 1992-03-04 | 2003-02-24 | Cell Therapeutics Inc | Enantiomere hydroxylerede xanthinforbindelser |
EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
US5288721A (en) * | 1992-09-22 | 1994-02-22 | Cell Therapeutics, Inc. | Substituted epoxyalkyl xanthines |
US5817662A (en) * | 1992-11-09 | 1998-10-06 | Cell Therapeutics, Inc. | Substituted amino alkyl compounds |
US5473070A (en) * | 1992-11-16 | 1995-12-05 | Cell Therapeutics, Inc. | Substituted long chain alcohol xanthine compounds |
US6693105B1 (en) | 1992-11-16 | 2004-02-17 | Cell Therapeutics, Inc. | Hydroxyl-containing compounds |
US5804584A (en) * | 1992-11-16 | 1998-09-08 | Cell Therapeutics, Inc. | Therapeutic compounds containing a monocyclic five- to six- membered ring structure having one to two nitrogen atoms |
US5866576A (en) * | 1992-12-16 | 1999-02-02 | Cell Therapeutics, Inc. | Epoxide-containing compounds |
AU6087894A (en) * | 1993-01-14 | 1994-08-15 | Cell Therapeutics, Inc. | Acetal or ketal substituted therapeutic compounds |
WO1994016704A1 (en) * | 1993-01-19 | 1994-08-04 | Cell Therapeutics, Inc. | Oxime-substituted therapeutic compounds |
US5641783A (en) * | 1993-11-12 | 1997-06-24 | Cell Therapeutics, Inc. | Substituted amino alcohol compounds |
US5837703A (en) * | 1993-03-31 | 1998-11-17 | Cell Therapeutics, Inc. | Amino-alcohol substituted cyclic compounds |
US6020337A (en) * | 1993-04-05 | 2000-02-01 | Cell Therapeutics, Inc. | Electronegative-substituted long chain xanthine compounds |
AU1831395A (en) * | 1994-01-14 | 1995-08-01 | Cell Therapeutics, Inc. | Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf |
WO1995022546A1 (en) * | 1994-02-18 | 1995-08-24 | Cell Therapeutics, Inc. | Intracellular signalling mediators |
US6103730A (en) * | 1994-03-24 | 2000-08-15 | Cell Therapeutics, Inc. | Amine substituted compounds |
US5807861A (en) * | 1994-03-24 | 1998-09-15 | Cell Therapeutics, Inc. | Amine substituted xanthinyl compounds |
US5801182A (en) * | 1994-03-24 | 1998-09-01 | Cell Therapeutics, Inc. | Amine substituted compounds |
DE19540798A1 (de) * | 1995-11-02 | 1997-05-07 | Hoechst Ag | Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel |
US5965555A (en) * | 1996-06-07 | 1999-10-12 | Hoechst Aktiengesellschaft | Xanthine compounds having terminally animated alkynol side chains |
US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
DE19707655A1 (de) * | 1997-02-26 | 1998-08-27 | Hoechst Ag | Kombinationspräparat zur Anwendung bei Demenz |
US6294350B1 (en) | 1997-06-05 | 2001-09-25 | Dalhousie University | Methods for treating fibroproliferative diseases |
US5985592A (en) * | 1997-06-05 | 1999-11-16 | Dalhousie University | Uses for pentoxifylline or functional derivatives/metabolites thereof |
US6075029A (en) * | 1998-01-02 | 2000-06-13 | Cell Therapeutics, Inc. | Xanthine modulators of metabolism of cellular P-450 |
US20030207901A1 (en) * | 1999-07-27 | 2003-11-06 | Cell Therapeutics, Inc. | Hydroxyl-containing compounds |
DE10042152A1 (de) * | 2000-08-26 | 2002-03-28 | Basf Coatings Ag | Mit aktinischer Strahlung aktivierbares Thixotropierungsmittel, Verfahren zu seiner Herstellung und seine Verwendung |
DE10122390A1 (de) * | 2001-05-09 | 2002-11-28 | Basf Coatings Ag | Carbamat-und/oder Allophanatgruppen enthaltende, thermisch härtbare, thixotrope Gemische |
DE10139262C1 (de) * | 2001-08-09 | 2003-01-02 | Basf Coatings Ag | Rheologiehilfsmittel, Verfahren zu seiner Herstellung und seine Verwendung |
AU2002304685A1 (en) * | 2002-04-24 | 2003-11-10 | Basf Coatings Ag | Thermally curable, thixotropic mixtures containing carbamate and/or allophanate groups |
KR100872788B1 (ko) * | 2002-05-28 | 2008-12-09 | 엘지전자 주식회사 | 드럼세탁기 |
US8686090B2 (en) * | 2003-12-10 | 2014-04-01 | Basf Coatings Gmbh | Use of urea crystals for non-polymeric coatings |
US20080081816A1 (en) * | 2006-10-03 | 2008-04-03 | Kaohsiung Medical University | Anti-inflammation activity of newly synthesized xanthine derivatives kmup-1 and kmup-3 |
BRPI0908107A2 (pt) * | 2008-02-29 | 2019-09-24 | Concert Pharmaceuticals Inc | composto derivado de xantina substituída, composição farmacêutica que compreende esse composto, métodos de tratamento de uma enfermidade ou condição em um paciente com necessidade do mesmo, método de tratamento de enfermidade crônica dos rins, do fígado, relacionada com diabetes e de claudicação intermitente |
KR20110014974A (ko) * | 2008-03-31 | 2011-02-14 | 썬 파마슈티컬 인더스트리스 리미티드 | 모르피난 유사체의 개선된 제조 방법 |
US8263601B2 (en) | 2009-02-27 | 2012-09-11 | Concert Pharmaceuticals, Inc. | Deuterium substituted xanthine derivatives |
WO2011028820A1 (en) | 2009-09-02 | 2011-03-10 | Concert Pharmaceuticals, Inc. | Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds |
WO2011028835A1 (en) | 2009-09-02 | 2011-03-10 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
WO2012031072A1 (en) | 2010-09-01 | 2012-03-08 | Concert Pharmaceuticals, Inc. | Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation |
WO2012031073A1 (en) | 2010-09-01 | 2012-03-08 | Concert Pharmaceuticals, Inc. | Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation |
WO2013155465A1 (en) | 2012-04-13 | 2013-10-17 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1245969B (de) * | 1967-08-03 | VEB Arzneimittelwerk Dresden, Radebeul | Verfahren zur Herstellung von Xanthinderivaten | |
US2517410A (en) * | 1947-08-15 | 1950-08-01 | Searle & Co | Hydroxy alkyl xanthines and the production thereof |
FR1211333A (fr) * | 1955-10-19 | 1960-03-15 | Boehringer Sohn Ingelheim | Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines |
US4576947A (en) * | 1967-12-16 | 1986-03-18 | Hoechst Aktiengesellschaft | Pharmaceutical compositions |
DE2335170C2 (de) * | 1973-07-11 | 1989-07-20 | Hoechst Ag, 6230 Frankfurt | 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
BE795345A (fr) * | 1972-02-19 | 1973-08-13 | Albert Ag Chem Werke | MEDICAMENT UTILE NOTAMMENT POUR L'IRRIGATION CEREBRALE, PROCEDE DE PREPARATION DE SES MATIERES ACTIVES ET CES MATIERES ElLES-MEMES |
CH622519A5 (en) * | 1974-07-05 | 1981-04-15 | Hoechst Ag | Process for the preparation of hydroxyalkylxanthines |
DE2432702C2 (de) * | 1974-07-08 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von Hydroxyalkylxanthinen |
CA1075690A (en) * | 1974-12-13 | 1980-04-15 | Hoechst Aktiengesellschaft | Xanthine derivatives |
EP0017478B1 (en) * | 1979-04-05 | 1983-03-30 | BEECHAM - WUELFING GmbH & Co. KG | Dialkoxy- and dioxacycloalkyl-alkyltheobromines, pharmaceutical compositions containing them and their preparation |
JPS5838284A (ja) * | 1981-09-01 | 1983-03-05 | Teikoku Chem Ind Corp Ltd | 1−(5′−オキソヘキシル)−3,7−ジメチルキサンチンの製造方法 |
DE3138397A1 (de) * | 1981-09-26 | 1983-04-07 | Hoechst Ag, 6230 Frankfurt | "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen" |
US4575795A (en) * | 1983-04-01 | 1986-03-11 | Honeywell Information Systems Inc. | Apparatus for detecting a predetermined character of a data string |
-
1985
- 1985-07-19 DE DE19853525801 patent/DE3525801A1/de not_active Withdrawn
-
1986
- 1986-07-08 EP EP86904158A patent/EP0268585B1/de not_active Expired - Lifetime
- 1986-07-08 KR KR1019870700245A patent/KR950001019B1/ko not_active IP Right Cessation
- 1986-07-08 JP JP61504113A patent/JPH0788382B2/ja not_active Expired - Lifetime
- 1986-07-08 AU AU61439/86A patent/AU588350B2/en not_active Ceased
- 1986-07-08 DE DE8686904158T patent/DE3671627D1/de not_active Expired - Fee Related
- 1986-07-08 RU SU864355018A patent/RU2051918C1/ru active
- 1986-07-08 HU HU863670A patent/HU198486B/hu not_active IP Right Cessation
- 1986-07-08 US US07/032,729 patent/US4833146A/en not_active Expired - Lifetime
- 1986-07-08 WO PCT/EP1986/000401 patent/WO1987000523A2/de active IP Right Grant
- 1986-07-08 AT AT86904158T patent/ATE53211T1/de not_active IP Right Cessation
- 1986-07-17 NZ NZ216888A patent/NZ216888A/xx unknown
- 1986-07-17 CS CS545386A patent/CS272766B2/cs unknown
- 1986-07-17 ES ES8600356A patent/ES2001019A6/es not_active Expired
- 1986-07-17 PH PH34027A patent/PH26262A/en unknown
- 1986-07-17 GR GR861866A patent/GR861866B/el unknown
- 1986-07-17 DD DD86292595A patent/DD261156A5/de not_active IP Right Cessation
- 1986-07-18 MX MX925486A patent/MX9254A/es unknown
- 1986-07-18 AR AR86304545A patent/AR244689A1/es active
- 1986-07-18 CN CN86105835A patent/CN1026112C/zh not_active Expired - Lifetime
- 1986-07-18 ZA ZA865374A patent/ZA865374B/xx unknown
- 1986-07-18 PT PT83013A patent/PT83013B/pt not_active IP Right Cessation
- 1986-07-18 IL IL79457A patent/IL79457A0/xx not_active IP Right Cessation
- 1986-07-18 MA MA20967A patent/MA20739A1/fr unknown
- 1986-07-18 TN TNTNSN86111A patent/TNSN86111A1/fr unknown
- 1986-07-18 IE IE191786A patent/IE59025B1/en not_active IP Right Cessation
- 1986-07-18 CA CA000514174A patent/CA1262248A/en not_active Expired
-
1987
- 1987-03-18 DK DK139287A patent/DK157867C/da not_active IP Right Cessation
- 1987-03-18 NO NO871111A patent/NO165803C/no not_active IP Right Cessation
-
1988
- 1988-01-15 FI FI880174A patent/FI89921C/fi not_active IP Right Cessation
- 1988-01-18 OA OA59264A patent/OA08707A/xx unknown
-
1993
- 1993-05-05 LV LV930291A patent/LV5703A3/xx unknown
- 1993-11-12 LT LTIP1467A patent/LT3869B/lt not_active IP Right Cessation
-
1994
- 1994-02-23 BG BG98535A patent/BG60767B2/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO871111L (no) | Tertiaere hydroksyalkylxantiner, fremgangsmaate til deres fremstilling, legemidler som inneholder dem og deres anvendelse. | |
DK328586D0 (da) | Phenylethanolaminotetraliner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem | |
DK56086D0 (da) | 11beta-phenylgonaner, deres fremstilling og farmaceutiske praeparaterindeholdende dem | |
NO871165L (no) | 2-azolylmetyl-2-aryl-1,3-dioksolaner og deres salter, fremgangsmaate til deres fremstilling, midler inneholdende dem og deres anvendelse. | |
DK362787A (da) | Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling | |
DK373787D0 (da) | Substituerede hydrazoner, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel | |
DK578585A (da) | Aminoacyllabdaner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse som laegemidler | |
DK218985A (da) | Aminocyklopentylaetere, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af dem | |
NO872778D0 (no) | Nye 4-pyridonderivater, fremgangsmaate til deres fremstilling og farmasoeytiske preparater som inneholder disse. | |
NO862976L (no) | Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling, og deres anvendelse. | |
DK504986D0 (da) | 7-acylbenzoxazinoner og deres derivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
DK266886A (da) | 5-amino-4-cyano-1-pyridylpyrazoler, en raekke fremgangsmaader til fremstilling deraf og deres anvendelse som herbicider | |
DK457787D0 (da) | Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling | |
DK425384D0 (da) | Acylindol-derivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater som indeholder dem | |
DK409786A (da) | 6-phenoxymethyl-4-hydroxytetrahydropyran-2-oner, fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler, pharmaceutiske praeparater og mellemprodukter | |
NO871745D0 (no) | Benzotiazinonderivater, fremgangsmaate til deres fremstilling, legemidler inneholdende dem og deres anvendelse. | |
NO871166L (no) | 2-azolylmetyl-2-aryl-1,3-dioksolaner og deres salter, fremgangsmaate til deres fremstilling, midler som inneholder dem og deres anvendelse. | |
NO871744D0 (no) | Nye benzotiazinonderivater, fremgangsmaate til deres fremstilling, legemidler som inneholder disse og deres anvendelse. | |
DK403585A (da) | Histargin-beslaegtede forbindelser, en fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
NO862917D0 (no) | Dihydrokinolinon-derivater, fremgangsmaate til deres fremstilling, legemidler som inneholder disse og deres anvendelse, samt mellomprodukter til deres fremstilling. | |
DK182186D0 (da) | Ethanobenzazepiner, fremgangsmaade og mellemprodukter til deres fremstilling og deres anvendelse som laegemidler | |
NO822534L (no) | Oxotienobenzooksepiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel | |
DK390186D0 (da) | Thiadiazolyloxyacetamider, fremgangsmaade til deres fremstilling og deres anvendelse som herbicider | |
DK110785A (da) | Carboxyalkyldipeptidderivater, fremgangsmaade til deres fremstilling, midler indeholdende dem og deres anvendelse | |
DK19085A (da) | Triazolylsubstituerede propanforbindelser, deres fremstilling og farmaceutiske praeparater, som indeholder dem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JANUARY 2003 |